Login to Your Account

Advent France Biotech raises $70M in first close of new seed fund

By Cormac Sheridan
Staff Writer

Friday, April 21, 2017

DUBLIN – French biotech has a new source of cash for early stage ventures. Advent France Biotechnology (AFB) has raised €64.75 million (US$69.7 million) in a first closing of a new seed fund, which has a mandate to back first or best-in-class breakthrough innovations that address unmet medical needs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription